Vaccine for Porcine Reproductive and Respiratory Syndrome Market

Vaccine for Porcine Reproductive and Respiratory Syndrome Market contains market size and forecasts of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) in global, including the following market information:

Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) companies in 2021 (%)

The global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Live Vaccine Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) include CNADC, Boehringer-Ingelheim, MSD Animal Health, Sinopharm, Ceva, Chengdu Tianbang Biological Products Co., Ltd., Tianjin Ruipu Biological Technology Co., Ltd., Qilu Animal Health and Guangdong Wens Dahuanong Biotechnology Co., Ltd., etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Segment Percentages, by Type, 2021 (%)

Live Vaccine

Inactivated Vaccine

Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Segment Percentages, by Application, 2021 (%)

Government Tender

Marketing

Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) revenues share in global market, 2021 (%)

Key companies Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) sales in global market, 2017-2022 (Estimated), (K Units)

Key companies Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

CNADC

Boehringer-Ingelheim

MSD Animal Health

Sinopharm

Ceva

Chengdu Tianbang Biological Products Co., Ltd.

Tianjin Ruipu Biological Technology Co., Ltd.

Qilu Animal Health

Guangdong Wens Dahuanong Biotechnology Co., Ltd.

CAVAC

Komipharm

Agrovet

Bioveta

Jinyu Bio-Technology

Phibro Animal Health

Tiankang

Zoetis

Guangdong Yongshun Biological Pharmaceutical Co Ltd

Plec Bioengineering Co., Ltd.